Ibn Sina Pharma’s income has increased

Staff Reporter: The Board of Directors of Ibn Sina Pharmaceuticals Industry Limited has released its unaudited financial report for the second quarter (October 21-December 21). The report was released at a meeting of the company’s board of directors on Thursday, January 20.

According to the company authorities, the company’s consolidated earnings per share (EPS) was 5.96 paise and the consolidated earnings per share (EPS) was 4.95 paise in the same period last fiscal.

The company’s earnings per share (EPS) for the six months (July, December 21-December 21) was Tk 10.49 and the earnings per share (EPS) for the same period last fiscal was Tk 6.19. At the same time, the company’s net asset value per share (NAV) was 74 rupees 49 paise.


Source: Daily StockBangladesh by www.dailystockbangladesh.com.

*The article has been translated based on the content of Daily StockBangladesh by www.dailystockbangladesh.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!